Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 07 Jan 2025

Real-world experiences with brentuximab vedotion-based regimens in systemic anaplastic large cell lymphoma: a multi-center retrospective study

in Hematologic Malignancies

Zhiqiang Zhao
Qinchuan Yu
Liping Su
Jianxia He
Jie Tao
Yanfeng Xi
Yujiao Guo
Yanhong Luo
Lieyang Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1494384

1,544 views
1 citation

Systematic Review

Published on 07 Jan 2025

The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis

in Hematologic Malignancies

Jile Liu
Yuxin An
Rui Sun
Xiaomei Zhang
Shujing Guo
Xuejin Gao
Mingfeng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2024.1478888

2,547 views

Original Research

Published on 07 Jan 2025

Investigating resistance to 5-Azacytidine and Venetoclax in PDX models of MDS/AML

in Hematologic Malignancies

Petra Bašová
Lubomír Minařík
Silvia Carina Magalhaes-Novais
Jana Balounová
Zuzana Zemanová
Tatiana Aghová
Martin Špaček
Anna Jonášová
Kristýna Gloc Pimková
Jan Procházka

Frontiers in Oncology

doi 10.3389/fonc.2024.1414950

2,223 views

Editorial

Published on 06 Jan 2025

Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment, volume II

in Hematologic Malignancies

Lokman Varisli
Garrett M. Dancik
John A. Copland
Spiros A. Vlahopoulos

Frontiers in Oncology

doi 10.3389/fonc.2024.1542306

746 views
1 citation

Original Research

Published on 06 Jan 2025

Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes

in Hematologic Malignancies

Lisa Dietsche
Kristin Stirm
Veronika Lysenko
Corina Schneidawind
Alexandar Tzankov
Anne Müller
Alexandre P. A. Theocharides

Frontiers in Oncology

doi 10.3389/fonc.2024.1481713

1,602 views
1 citation

Original Research

Published on 06 Jan 2025

Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unit

in Hematologic Malignancies

Panagiotis Karagiannis
Felix Klingler
Viktor Arelin
Winfried Alsdorf
Christina König
Kevin Roedl
Walter Fiedler
Katja Weisel
Stefan Kluge
Carsten Bokemeyer

Frontiers in Oncology

doi 10.3389/fonc.2024.1508112

1,756 views

Original Research

Published on 06 Jan 2025

Prognostic risk factors of pneumonia associated with COVID-19 in patients with lymphoma

in Hematologic Malignancies

Dan Liu
Xia Yin
Hui Wang
Lijie Xing
Ping Li
Haichen Wei
Ji Ma
Qiang He
Linna Xie
Ke Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1504809

1,130 views

Case Report

Published on 06 Jan 2025

Case report: a 3-year follow-up on nodal marginal zone lymphoma coexisting with disseminated Talaromyces marneffei infection in a non-endemic area

in Hematologic Malignancies

Xiping Yu
Houyun Xu
Junjie Zhou
Zhiqiang Zhu
Baizhou Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1407893

861 views

Review

Published on 24 Dec 2024

BTK inhibition in primary central nervous system lymphoma: mechanisms, clinical efficacy, and future perspectives

in Hematologic Malignancies

Yurou Xing
Kejia Zhao
Yi Zhang
Yongsheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1463505

2,096 views

Case Report

Published on 19 Dec 2024

Selinexor in combination with venetoclax and decitabine in patients with refractory myelodysplastic syndrome previously exposed to hypomethylating agents: three case reports

in Hematologic Malignancies

Yunshuo Xiao
Kun Yang
Qiuying Huang
Changqing Wei
Manlv Wei
Zhili Geng
Hui Wu
Tianhong Zhou
Xialoin Yin
Yali Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1477697

1,456 views
1 citation

Case Report

Published on 17 Dec 2024

Obinutuzumab-induced acute thrombocytopenia: a case report and literature review

in Hematologic Malignancies

Xuelin Dou
Kongyang Li
Jin Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1509567

1,427 views

Clinical Trial

Published on 16 Dec 2024

A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma

in Hematologic Malignancies

Jeffrey J. Pu
Kristin N. Berger
Chunlei Zheng
Nhan Do
David F. Claxton
W. Christopher Ehmann
Joseph J. Drabick
Haiquan Li
Thomas P. Loughran
Elliot M. Epner

Frontiers in Oncology

doi 10.3389/fonc.2024.1449401

1,595 views

Case Report

Published on 12 Dec 2024

Chronic myelogenous leukemia coexpressing V-e16a2, V-e13a2, e13a2, and e14a2 BCR::ABL1 fusion transcripts: a case report and review of the literature

in Hematologic Malignancies

Yang Xu
Yuying Fan
Sijin Liu
Jianmei Chang
Caifeng Guo
Lanhui Chen
Wenzheng Guo
Jinwen Dang
Hongwei Wang
Yanhong Tan

Frontiers in Oncology

doi 10.3389/fonc.2024.1518387

905 views

Correction

Published on 11 Dec 2024

Corrigendum: Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool

in Hematologic Malignancies

Lina U. Ivert
Anna H. Winther
Pontus Jonsson
Hanna Brauner

Frontiers in Oncology

doi 10.3389/fonc.2024.1504102

675 views

Case Report

Published on 11 Dec 2024

Preoperative diagnosis of primary ovarian lymphoma: a case report and a decade of insights

in Hematologic Malignancies

Wei Liu
Houyun Xu
Jibo Hu
Xiping Yu
Junjie Zhou
Hongjie Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1471654

838 views

Case Report

Published on 10 Dec 2024

Severe atypical skin disease in two patients with CLL/SLL after BTKi treatment - a case report and literature review

in Hematologic Malignancies

Jingxin Zhou
Wentong Ma
Na Hu
Yuhan Ma
Huayuan Zhu
Ling Gao

Frontiers in Oncology

doi 10.3389/fonc.2024.1467891

1,251 views
1 citation